Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning the Use of Magnetism To Inactivate, Kill and/or Remove Malaria Parasites From Transfused Blood and Apparatus and Kits for Accomplishing the Same, 4025 [2012-1657]

Download as PDF Federal Register / Vol. 77, No. 17 / Thursday, January 26, 2012 / Notices 1201 Pennsylvania Ave. NW., Washington, DC 20004, Counsel for Hewlett-Packard Company. U.S. Consumer Product Safety Commission Staff. Cheryl A. Falvey, General Counsel. Melissa V. Hampshire, Assistant General Counsel. Dated: January 9, 2012. By: lllllllllllllllllll Amy S. Colvin, General Attorney, Division of Enforcement and Information, Office of the General Counsel. Order Upon consideration of the Settlement Agreement entered into between Hewlett-Packard Company (‘‘HP’’), and the U.S. Consumer Product Safety Commission (‘‘Commission’’) staff, and the Commission having jurisdiction over the subject matter and over HP, and it appearing that the Settlement Agreement and the Order are in the public interest, it is Ordered that the Settlement Agreement be, and hereby is, accepted; and it is Further ordered that HP shall pay a civil penalty in the amount of four hundred twenty-five thousand dollars ($425,000.00) within twenty (20) calendar days of service of the Commission’s final Order accepting the Settlement Agreement. The payment shall be made by check payable to the order of the United States Treasury. Upon the failure of HP to make the foregoing payment when due, interest on the unpaid amount shall accrue and be paid by HP at the federal legal rate of interest set forth at 28 U.S.C. 1961(a) and (b). Provisionally accepted and provisional Order issued on the 20th day of January, 2012. By Order of the Commission: Todd A. Stevenson, Secretary, U.S. Consumer Product Safety Commission. [FR Doc. 2012–1644 Filed 1–25–12; 8:45 am] BILLING CODE 6355–01–P DEPARTMENT OF DEFENSE Office of the Secretary mstockstill on DSK4VPTVN1PROD with NOTICES Privacy Act of 1974; System of Records U.S. Central Command, DoD. ACTION: Notice to Amend a System of Records. AGENCY: The U.S. Central Command is amending a system of records notice in VerDate Mar<15>2010 17:14 Jan 25, 2012 Jkt 226001 This proposed action will be effective on February 27, 2012 unless comments are received which result in a contrary determination. DATES: You may submit comments, identified by docket number and title, by any of the following methods: * Federal Rulemaking Portal: https:// www.regulations.gov. Follow the instructions for submitting comments. * Mail: Federal Docket Management System Office, 4800 Mark Center Drive, East Tower, 2nd Floor, Suite 02G09, Alexandria, VA 22350–3100. Instructions: All submissions received must include the agency name and docket number for this Federal Register document. The general policy for comments and other submissions from members of the public is to make these submissions available for public viewing on the Internet at https:// www.regulations.gov as they are received without change, including any personal identifiers or contact information. ADDRESSES: Ms. Evlyn Hearne, USCENTCOM CCJ6–RDF, 7115 South Boundary Blvd., MacDill AFB, FL 33621–5101 or at (813) 827– 7482. FOR FURTHER INFORMATION CONTACT: The U.S. Central Command systems of records notices subject to the Privacy Act of 1974 (5 U.S.C. 552a), as amended, have been published in the Federal Register and are available from the address in FOR FURTHER INFORMATION CONTACT. The U.S. Central Command proposes to amend one system of records notice from its inventory of record systems subject to the Privacy Act of 1974 (5 U.S.C. 552a), as amended. The proposed amendment is not within the purview of subsection (r) of the Privacy Act of 1974 (5 U.S.C. 552a), as amended, which requires the submission of a new or altered system report. SUPPLEMENTARY INFORMATION: Dated: January 23, 2012. Aaron Siegel, Alternate OSD Federal Register Liaison Officer, Department of Defense. [Docket ID DOD–2012–OS–0010] SUMMARY: its existing inventory of record systems subject to the Privacy Act of 1974 (5 U.S.C. 552a), as amended. DPR 41 DoD SYSTEM NAME: Combined Mild Traumatic Brain Injury Registry (September 30, 2010, 75 FR 60431). PO 00000 Frm 00028 Fmt 4703 Sfmt 9990 4025 CHANGES: Change system ID to read ‘‘FCENTCOM 01’’. * * * * * [FR Doc. 2012–1615 Filed 1–25–12; 8:45 am] BILLING CODE 5001–06–P DEPARTMENT OF DEFENSE Department of the Army Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning the Use of Magnetism To Inactivate, Kill and/or Remove Malaria Parasites From Transfused Blood and Apparatus and Kits for Accomplishing the Same AGENCY: ACTION: Department of the Army, DoD. Notice. The invention relates to preventing and/or reducing the incidence of transfusion-related malaria, and the use of magnetism to accomplish this. Announcement is made of the availability for licensing of the invention set forth in U.S. Provisional Patent Application Serial No. 61/ 584,977, entitled ‘‘Use of Magnetism to Inactivate, Kill and/or Remove Malaria Parasites from Transfused Blood and Apparatus and Kits for Accomplishing the same,’’ filed on January 10, 2012. The United States Government, as represented by the Secretary of the Army, has rights to this invention. SUMMARY: Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR–JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702– 5012. ADDRESSES: For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619–7808. For licensing issues, Dr. Paul Mele, Office of Research and Technology Applications (ORTA), (301) 619–6664, both at telefax (301) 619–5034. FOR FURTHER INFORMATION CONTACT: The invention relates to methods of preventing or reducing the incidence of transfusion-related malaria, and, in particular, to inactivating, killing and/or removing malaria parasites from blood supplies such as whole blood, platelets, plasma or other components of blood. SUPPLEMENTARY INFORMATION: Brenda S. Bowen, Army Federal Register Liaison Officer. [FR Doc. 2012–1657 Filed 1–25–12; 8:45 am] BILLING CODE 3710–08–P E:\FR\FM\26JAN1.SGM 26JAN1

Agencies

[Federal Register Volume 77, Number 17 (Thursday, January 26, 2012)]
[Notices]
[Page 4025]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-1657]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Notice of Availability for Exclusive, Non-Exclusive, or 
Partially-Exclusive Licensing of an Invention Concerning the Use of 
Magnetism To Inactivate, Kill and/or Remove Malaria Parasites From 
Transfused Blood and Apparatus and Kits for Accomplishing the Same

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The invention relates to preventing and/or reducing the 
incidence of transfusion-related malaria, and the use of magnetism to 
accomplish this. Announcement is made of the availability for licensing 
of the invention set forth in U.S. Provisional Patent Application 
Serial No. 61/584,977, entitled ``Use of Magnetism to Inactivate, Kill 
and/or Remove Malaria Parasites from Transfused Blood and Apparatus and 
Kits for Accomplishing the same,'' filed on January 10, 2012. The 
United States Government, as represented by the Secretary of the Army, 
has rights to this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research and Technology Applications (ORTA), (301) 619-
6664, both at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: The invention relates to methods of 
preventing or reducing the incidence of transfusion-related malaria, 
and, in particular, to inactivating, killing and/or removing malaria 
parasites from blood supplies such as whole blood, platelets, plasma or 
other components of blood.

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2012-1657 Filed 1-25-12; 8:45 am]
BILLING CODE 3710-08-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.